Before the first effective polio vaccine became available in 1955, polio had killed hundreds of thousands of people in the United States alone. The exact global death toll is unknown, but reliable records show that during the worst years of the 20th century, polio killed thousands of Americans annually. In the peak year of 1952, the United States reported nearly 58,000 polio cases, and more than 3,000 of those people died. The disease did not just kill—it permanently paralyzed thousands more, many of them children.
How Many People Died From Polio Before The Vaccine?
Before the vaccine, polio was one of the most feared diseases in America. During the 1940s and 1950s, the United States experienced repeated epidemics. In 1952, the worst year on record, there were 57,879 reported cases of paralytic polio. Of those, 3,145 people died. That single year represents the peak of the American epidemic, but the death toll stretched across decades.
From the late 1940s through the early 1950s, the United States averaged roughly 35,000 to 50,000 polio cases per year. During those same years, annual deaths from polio typically numbered between 1,500 and 3,000. Millions of Americans lived with the fear that summer would bring another outbreak, closing pools, theaters, and schools.
Globally, the numbers are far harder to pin down. Many countries did not keep reliable disease records before the 1950s. What is certain is that polio existed on every continent and killed and disabled people everywhere it appeared. The World Health Organization estimates that before the global eradication effort began in 1988, polio paralyzed roughly 350,000 people per year worldwide. The death rate among those paralyzed has historically been estimated at 5 to 10 percent, which would place the global annual death toll in the tens of thousands before vaccination became widespread.
Why Did Polio Kill So Many People?
Polio is caused by the poliovirus, which spreads through contaminated water and food, and through contact with an infected person’s stool. Most people infected with the virus—around 95 percent—show no symptoms at all. About 4 to 5 percent develop a mild illness with fever, sore throat, and headache. In fewer than 1 percent of cases, the virus attacks the central nervous system.
When the virus reaches the nervous system, it can destroy motor neurons in the spinal cord. These are the nerve cells that tell muscles to move. When they die, the muscles they control stop working. This is paralysis. If the paralysis affects the muscles used for breathing, the person cannot breathe without mechanical help. Before the 1950s, that help came in the form of the iron lung—a large metal cylinder that created negative pressure to pull air into the lungs.
Death from polio usually resulted from respiratory failure or from complications of paralysis, such as pneumonia. The case fatality rate for paralytic polio has been reported at roughly 5 to 10 percent in historical outbreaks. In some severe epidemics, particularly those affecting adults, the death rate was higher.
Who Was Most At Risk Of Dying From Polio?
Polio is often remembered as a childhood disease, and it was. But the deadliest pattern was different. In the early 20th century, as sanitation improved, the age of first exposure to the virus shifted. In the 1800s, most infants were exposed to the virus in the first months of life, when they still carried protective antibodies from their mothers. These early infections were usually mild or silent.
As sanitation improved, many children escaped early exposure. They met the virus for the first time at age five, ten, or older. By then, maternal antibodies were long gone. Older children and adults who contract polio are more likely to develop paralytic disease than infants are. Adults with paralytic polio also have a higher death rate than children with the same condition.
During the 1952 epidemic, the majority of polio deaths occurred in children, simply because children made up most of the cases. But the risk of dying from a case of paralytic polio was highest in older patients. Some historical studies from the 1940s and 1950s reported case fatality rates above 20 percent in adults over age 40.
What Changed When The Vaccine Arrived?
The first successful polio vaccine was developed by Jonas Salk and licensed in 1955. It was an inactivated vaccine, given by injection. Within a few years, cases of paralytic polio in the United States dropped dramatically. By 1961, fewer than 1,000 cases were reported nationwide. By the late 1960s, that number had fallen below 100.
Albert Sabin’s oral polio vaccine, licensed in the early 1960s, made vaccination easier and cheaper. It could be given on a sugar cube and did not require trained medical personnel for injection. The oral vaccine became the backbone of mass immunization campaigns worldwide.
The impact was immediate and measurable. In the United States, the number of polio deaths fell from 3,145 in 1952 to just a handful by the mid-1960s. By 1979, the United States was declared free of wild poliovirus transmission. The Americas followed in 1994. Today, wild poliovirus remains endemic in only two countries: Afghanistan and Pakistan.
How Does The Historical Death Toll Compare To Other Diseases?
Polio’s death toll is often compared to other infectious diseases of the same era. Influenza was far deadlier. The 1918 flu pandemic alone killed an estimated 675,000 Americans in a single year. Tuberculosis killed tens of thousands of Americans annually well into the 1940s. Measles killed several hundred Americans per year before its vaccine was introduced in 1963.
But polio was different in one important way. It struck during the summer, when people expected safety. It paralyzed healthy children seemingly at random. It filled hospital wards with iron lungs. The fear polio generated was out of proportion to its death count, but the disease’s ability to disable was real and lasting. Many of those who survived paralytic polio lived with disability for decades.
The long-term consequences of polio also continued to claim lives. Post-polio syndrome, a condition of new muscle weakness appearing decades after the initial infection, affects many polio survivors. Some of those who survived respiratory paralysis in the 1950s eventually died of complications related to weakened respiratory muscles.
What Can We Learn From The Historical Record?
The history of polio before the vaccine is a clear example of what a vaccine can accomplish. The disease did not disappear on its own. It did not become milder over time. It stopped being a major cause of death and disability only after mass vaccination became routine.
Accurate historical records matter for another reason. They help us measure the true burden of disease. When a disease is eliminated, it is easy to forget how serious it was. The numbers from 1952—nearly 58,000 cases and more than 3,000 deaths in the United States alone—are a reminder of what happens when a highly infectious virus meets a population with no immunity.
The global picture today is far different. Wild poliovirus cases worldwide are down by more than 99 percent since 1988. The remaining cases are concentrated in small geographic areas. The tools to finish the job exist. The historical record shows that those tools work.
Frequently Asked Questions
How many people died from polio in the worst year in the US?
In 1952, more than 3,000 people died from polio in the United States, out of nearly 58,000 reported cases. That was the worst single year of the American polio epidemic.
Did polio kill more children or adults?
Children made up the majority of polio cases and deaths because they were the most exposed group. However, adults who developed paralytic polio had a higher chance of dying from it than children did.
Was polio deadly before the vaccine?
Yes, but most infections were not fatal. Roughly 95 percent of polio infections caused no symptoms, and paralysis occurred in less than 1 percent of cases. Among those with paralytic polio, the death rate was historically about 5 to 10 percent.
How many people get polio today?
Wild poliovirus is now endemic in only two countries, Afghanistan and Pakistan, with fewer than a few hundred cases reported globally each year in recent years. Cases outside those countries are extremely rare and almost always linked to imported virus or vaccine-derived strains.

